← Back to headlines
Legend Biotech Shares Decline After $226M Public Offering
Legend Biotech's shares experienced a slide following the pricing of its $226 million public offering at $29.35 per unit.
18 Jun, 05:57 — 18 Jun, 05:57
Sources
Showing 1 of 1 sources
Related Stories
Brookfield Structures $1.8 Billion Bond Deal to Fund $600 Million Dividend
46m ago
Nigeria Reports 4.43 Percent Economic Growth in Second Quarter
51m ago
Prediction Platform Kalshi Permanently Bans George Santos Over Insider Trading
53m ago
Pabst Brewing Offers 'No Questions Asked' Reward for Stolen Beer
1h ago